Fasting and Time-Restricted Eating

The hype far outran the human RCTs. Once they caught up, intermittent fasting turned out to be roughly as effective as continuous calorie restriction — no more, no less. Useful for some, but not the longevity breakthrough it was sold as.

Intermittent fasting (IF) has been the most popular dietary "movement" of the past decade. The honest evidence summary: it works for weight loss to roughly the same extent as continuous calorie restriction, with some specific benefits for glycemic control and metabolic flexibility, but it's not a longevity breakthrough.

The four main protocols

Time-restricted eating (TRE)

  • Eat within a specific daily window (typically 6–10 hours).
  • Most popular: 16:8 (16-hour fast, 8-hour eating window).
  • Early TRE (eating window ending ~17:00) is metabolically superior to late TRE (eating window ending after 19:00) — even at matched calories.

Alternate-day fasting (ADF)

  • Alternating days of normal eating and severely restricted eating (~25% of energy needs).
  • Often produces ~5–8% weight loss over 8–12 weeks; adherence drops significantly long-term.

Periodic fasting (PF)

  • Multi-day fasts (24–72 hours, sometimes longer).
  • Stronger autophagy signals; significant practical and adherence challenges.

Fasting-mimicking diet (FMD)

  • 5-day low-calorie, low-protein, plant-based protocol (Valter Longo's protocol).
  • Designed to trigger fasting biology while still allowing some food.
  • Typically 4 cycles per year.

What the evidence actually says

Weight loss

  • A 2026 Cochrane review of 22 RCTs (n=1,995) found IF did not produce significantly more weight loss than standard dietary advice or continuous calorie restriction.[1]
  • The 2025 BMJ network meta-analysis of 99 RCTs (n=6,582) found all IF strategies produce weight loss vs. ad-libitum eating, but the difference vs. continuous restriction is marginal. Alternate-day fasting was the only strategy with a slight statistical advantage (−1.29 kg) over continuous restriction in shorter trials. Differences vanished entirely in trials >24 weeks.[2]

Glycemic control

  • Modest improvements in fasting glucose, insulin, and HbA1c.
  • Strongest in T2D and prediabetic populations. Meta-analyses show IF as adjuvant therapy reduces HbA1c by ~0.5% (oral hypoglycemic users) up to ~2.8% (insulin-dependent — with strict supervision required to avoid hypoglycemia).[3]
  • Early TRE specifically shows the most consistent improvements in fasting insulin (−3.32 μIU/mL vs. late TRE).[4]

Autophagy

  • Single FMD cycles induce measurable autophagy markers (LC3B-II/I ratio) in human peripheral blood cells, persisting through refeeding.
  • Ramadan fasting upregulates Beclin-1 and downregulates LC3B / p62 — biological markers of active autophagy.
  • However, age-related decline in autophagic capacity means older adults respond less robustly than younger adults.

Cardiometabolic risk

  • Modest improvements in BP, lipids, and inflammatory markers across most protocols.
  • Less consistent than for weight or glucose.

Longevity (hard outcomes)

  • No human RCT has tested whether IF extends lifespan.
  • Animal data (rodents, nematodes, yeast) consistently show lifespan extension under various caloric restriction and fasting protocols, but human translation is uncertain.

Concerning signals

  • A 2024 American Heart Association abstract reported a 91% increase in cardiovascular mortality in those with eating windows <8 hours in a NHANES analysis. Still observational and contested, but worth knowing.[5]
  • Severe TRE (<6 hour eating windows) sustained long-term has not been adequately studied for safety.
  • Refeeding after extended fasts has been associated in some animal models with paradoxical increases in tumorigenesis — the "refeeding paradox". Human relevance unclear.[6]

Early vs. late time-restricted eating

This is one of the more robust findings. Multiple meta-analyses converge:

  • Early TRE (last meal before 17:00, eating window concentrated in morning/midday) is associated with:

    • Lower fasting insulin
    • Better body composition
    • Improved glycemic control
    • Better sleep quality (when last meal is well before bedtime)
  • Late TRE (last meal after 19:00):

    • Modest improvements over no restriction
    • Less metabolic benefit despite same total fasting hours
    • Worse sleep architecture

Why? Insulin sensitivity declines through the day. Glucose tolerance is much better at breakfast than at dinner. Late eating also pushes core body temperature and pre-sleep metabolic activity, degrading sleep.

Practical implication: A breakfast + lunch + light early dinner pattern aligns with circadian biology. "Skip breakfast, big late dinner" may be the worst chronotype for IF.

Resistance training during fasting

The training-fasting interaction matters:

  • Resistance training requires adequate protein and energy intake — fasted training is fine, but post-training feeding (with protein) supports adaptation.
  • A 16:8 eating window is fully compatible with hypertrophy — most adults can hit ~150 g protein in an 8-hour window if they plan.
  • Pre-bed protein (40 g casein or similar) has evidence (Snijders 2015) for overnight muscle protein synthesis. This conflicts with strict early-TRE protocols.

The reasonable compromise: most days do early TRE (eating window 8–10 hours, last meal ~17:00–19:00), but on heavy training days, allow flexibility — including a post-training meal even if it pushes the window slightly later.

Who should not fast

  • Pregnancy and lactation
  • Type 1 diabetes (without medical supervision)
  • History of eating disorders — IF can trigger or reinforce restrictive patterns
  • Underweight individuals
  • Children and adolescents
  • Insulin or sulfonylurea users — extreme hypoglycemia risk; only under medical supervision
  • Frail older adults — protein intake is more important than fasting; sarcopenia risk

Practical protocols

For most healthy midlife adults, the simplest evidence-based starting point:

Daily early TRE

  • 12–14 hour overnight fast (e.g., last bite at 19:00, first food at 7:00–9:00 the next morning)
  • Aligns with circadian biology
  • Effortlessly compatible with normal social patterns
  • Low downside risk

More aggressive: 16:8 with early window

  • Eat between 9:00–17:00 or 10:00–18:00
  • Strong metabolic signal
  • Compatible with morning training

Periodic deeper fasts

  • A 24-hour fast (e.g., dinner-to-dinner) once weekly is a moderate intervention
  • Or 1 FMD cycle (5 days) per year for those drawn to the autophagy framework

What to skip: Aggressive ADF, multi-day water-only fasts without medical supervision, OMAD (one meal a day) sustained long-term — adherence and metabolic side effects are real.

Further reading

  • BMJ 2025 network meta-analysis of intermittent fasting strategies (99 RCTs).[7]
  • Sutton EF et al. Early time-restricted feeding improves insulin sensitivity even without weight loss in men with prediabetes. Cell Metab 2018.[8]
  • Patterson RE, Sears DD. Metabolic effects of intermittent fasting. Annu Rev Nutr 2017.[9]
  • Wei M et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and CVD. Sci Transl Med 2017.[10]
  • IF and HbA1c in T2D — meta-analysis 2025.[11]
  • TRE eating-window timing meta-analysis (early vs. late).[12]
  • AHA: 8-hour time-restricted eating linked to 91% higher CV mortality risk.[13]
  • Critical Assessment of Fasting to Promote Metabolic Health and Longevity.[14]

— § —